참고문헌
- Batchelor PE, Liberatore GT, Wong JY, Porritt MJ, Frerichs F, Donnan GA, Howells DW. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell linederived neurotrophic factor. J Neurosci 19: 1708-1716, 1999
- Brundin P, Isacson O, Bjorklund A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res 331: 251-259, 1985 https://doi.org/10.1016/0006-8993(85)91550-1
- Choi-Lundberg DL, Lin Q, Yung-Nien C, Chiang YL, Hay CM, Mohajeri H, Davidson BL, Bohn MC. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275: 838-841, 1997 https://doi.org/10.1126/science.275.5301.838
- Espejo M, Cutillas B, Arenas TE, Ambrosio S. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell linederived neurotrophic factor. Cell Transplant 9: 45-53, 2000
- Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344: 710-719, 2001 https://doi.org/10.1056/NEJM200103083441002
- Ho A, Blum M. Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1 beta in the striatum of young and middle-aged mice. Exp Neurol 148: 348-359, 1997 https://doi.org/10.1006/exnr.1997.6659
- Joo WS, Jin BK, Park CW, Maeng SH, Kim YS. Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats. Neuroreport 9: 4123-4126, 1998 https://doi.org/10.1097/00001756-199812210-00022
- Kim YS, Joo WS, Jin BK, Cho YH, Baik HH, Park CW. Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system. Neuroreport 9: 2387-2390, 1998 https://doi.org/10.1097/00001756-199807130-00043
- Kirik D, Rosenblad C, Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 152: 259-277, 1998 https://doi.org/10.1006/exnr.1998.6848
- Kirik D, Rosenblad C, Bjorklund A. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Eur J Neurosci 12: 3871-3882, 2000. https://doi.org/10.1046/j.1460-9568.2000.00274.x
- Kirik D, Winkler C, Bjorklund A. Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J Neurosci 21: 2889-2896, 2001
- Lee CS, Sauer H, Bjorklund A. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat. Neuroscience 72: 641-653, 1996 https://doi.org/10.1016/0306-4522(95)00571-4
- Lindvall O. Neural transplantation. Cell Transplant 4: 393-400, 1995 https://doi.org/10.1016/0963-6897(95)00022-P
- Moukhles H, Amalric M, Nieoullon A, Daszuta A. Behavioural recovery of rats grafted with dopamine cells after partial striatal dopaminergic depletion in a conditioned reaction-time task. Neuroscience 63: 73-84, 1994 https://doi.org/10.1016/0306-4522(94)90008-6
- Paxinos G, Watson C. The rat brain in stereotaxic coordinates. In: 2nd ed. Academic press, San Diego, 1986
- Plunkett RJ, Ip NY, Asada H, Friedman B, Pan L, Kaseloo PA, Parfitt MM. Trauma-induced striatal CNTF and BDNF mRNA in hemiparkinsonian rats. Neuroreport 8: 507-511, 1997 https://doi.org/10.1097/00001756-199701200-00026
- Przedborski S, Levivier M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 67:631-647, 1995 https://doi.org/10.1016/0306-4522(95)00066-R
- Rodter A, Winkler C, Samii M, Nikkhah G. Complex sensorimotor behavioral changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts. Cell Transplant 9: 197-214, 2000 https://doi.org/10.1177/096368970000900206
- Satake K, Matsuyama Y, Kamiya M, Kawakami H, Iwata H, Adachi K, Kiuchi K. Up-regulation of glial cell line-derived neurotrophic factor (GDNF) following traumatic spinal cord injury. Neuroreport 11: 3877-3881, 2000 https://doi.org/10.1097/00001756-200011270-00054
- Sauer H, Oertel WH. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59: 401-415, 1994 https://doi.org/10.1016/0306-4522(94)90605-X
- Shults CW, Kimber T, Martin D. Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine. Neuroreport 7: 627 -631, 1996 https://doi.org/10.1097/00001756-199601310-00060
- Tonder N. Neural transplantation to the normal and lesioned brain. An experimental study of the rat hippocampus. Acta Neurol Scand Suppl 160: 1-30, 1995
- Tseng JL, Baetge EE, Zurn AD, Aebischer P. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J Neurosci 17: 325-333, 1997
- Ungerstedt U, Arbuthnott GW. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24: 485-493, 1970 https://doi.org/10.1016/0006-8993(70)90187-3